Superworth

Charles River Laboratories International price to free cash flow CRL

Market value divided by free cash flow over the last twelve months, since 2011.

Today, Nov 2, 2026
43.6×
10-year median
23.9×
Against its 10-year history
96th
percentile: 0 is its lowest day, 100 its highest
10-year range
10.2× to 47.7×
Peer median
26.7×

Charles River Laboratories International's price to free cash flow is 43.6× as of Nov 2, 2026.

That is above its ten-year median of 23.9×, higher than on 96% of days in the last ten years.

Over that time it ranged from 10.2× in Apr 2025 to 47.7× in Sep 2021.

The median for 10 diagnostics and research stocks of a similar size is 26.7×.

Price to free cash flow over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far43.6×14.6×46.3×
202518.4×10.2×18.4×
202417.0×16.9×38.3×
202332.9×23.9×45.5×
202239.6×22.9×44.8×
202142.1×28.9×47.7×
202027.8×15.2×29.9×
201925.2×16.2×26.0×
201816.5×16.3×24.5×
201722.7×16.2×22.7×
201615.6×14.0×17.0×
201516.8×14.8×20.4×
201417.6×15.0×17.8×
201314.9×11.6×14.9×
201211.6×8.4×13.6×
20118.2×7.9×17.9×

Against its peers

Companies in Medical - Diagnostics & Research nearest Charles River Laboratories International's size, closest first, today.

CompanyPrice to free cash flow
CRLCharles River Laboratories International43.6×
RVTYRevvity30.3×
MEDPMedpace25.6×
BIOBio-Rad Laboratories27.7×
DGXQuest Diagnostics20.0×
CAICaris Life Sciences73.2×
LHLabcorp25.0×
MTDMettler-Toledo International39.6×
ILMNIllumina38.4×
LNTHLantheus16.9×
IQVIQVIA19.4×
Peer median26.7×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Charles River Laboratories International

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.